• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体抗炎药尼美舒利的四烷基铵盐的合成、热行为、光谱和结构表征以及药代动力学参数的计算机预测

The synthesis, thermal behaviour, spectral and structural characterization, and in silico prediction of pharmacokinetic parameters of tetraalkylammonium salts of non-steroidal anti-inflammatory drug nimesulide.

作者信息

Rybczyńska Małgorzata, Sikorski Artur

机构信息

Faculty of Chemistry, University of Gdańsk, W. Stwosza 63, 80-308, Gdańsk, Poland.

出版信息

Sci Rep. 2023 Oct 12;13(1):17268. doi: 10.1038/s41598-023-44557-x.

DOI:10.1038/s41598-023-44557-x
PMID:37828142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10570311/
Abstract

The synthesis, spectral properties, thermal analysis, structural characterization and in silico prediction of pharmacokinetic parameters of tetramethylammonium (compound 1) and tetraethylammonium (compound 2) salt of nimesulide were described in this article. Both compounds crystallize in the monoclinic P2/n space group, with one tetraalkylammonium cation and one nimesulide anion in the asymmetric unit and their crystal structures are stabilized by C-H···O hydrogen bonds between ions. Additionally, structures of title compounds are stabilized by π-π interactions (compound 1), or C-H···π interactions (compound 2) between nimesulide anions. The TG and DSC measurements show that compound 1 melts at a temperature higher than nimesulide, whereas the compound 2 melts at a temperature lower than nimesulide. The MALDI-TOF, H NMR, C NMR and ATR-FTIR analyses confirm the SCXRD study, that in compounds 1 and 2 nimesulide exists in an ionized form. Studies performed by SWISS ADME and ProTOX II tools, predict to be oral bioavailability of both salts obtained, and one of them (compound 1) is predicted to be well-absorbed by digestive system, while both compounds obtained are classified into toxicity class 4.

摘要

本文描述了尼美舒利的四甲基铵盐(化合物1)和四乙基铵盐(化合物2)的合成、光谱性质、热分析、结构表征以及药代动力学参数的计算机预测。两种化合物均结晶于单斜P2/n空间群,不对称单元中含有一个四烷基铵阳离子和一个尼美舒利阴离子,其晶体结构通过离子间的C-H···O氢键得以稳定。此外,标题化合物的结构还通过尼美舒利阴离子之间的π-π相互作用(化合物1)或C-H···π相互作用(化合物2)得以稳定。热重(TG)和差示扫描量热(DSC)测量表明,化合物1的熔点高于尼美舒利,而化合物2的熔点低于尼美舒利。基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)、氢核磁共振(¹H NMR)、碳核磁共振(¹³C NMR)和衰减全反射傅里叶变换红外光谱(ATR-FTIR)分析证实了单晶X射线衍射(SCXRD)研究的结果,即化合物1和2中的尼美舒利以离子化形式存在。通过SWISS ADME和ProTOX II工具进行的研究预测了所获得的两种盐的口服生物利用度,其中一种(化合物1)预计可被消化系统良好吸收,而所获得的两种化合物均被归类为4类毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/d51303ec9efb/41598_2023_44557_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/ab5ccc2cef5e/41598_2023_44557_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/a65ab993cd07/41598_2023_44557_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/51efae991f53/41598_2023_44557_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/9d0aa2fddfbb/41598_2023_44557_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/2e9b797e1795/41598_2023_44557_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/7a0a143658e9/41598_2023_44557_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/8b225f1760ca/41598_2023_44557_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/4f03a0dbf07d/41598_2023_44557_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/b377bd37f55a/41598_2023_44557_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/d51303ec9efb/41598_2023_44557_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/ab5ccc2cef5e/41598_2023_44557_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/a65ab993cd07/41598_2023_44557_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/51efae991f53/41598_2023_44557_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/9d0aa2fddfbb/41598_2023_44557_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/2e9b797e1795/41598_2023_44557_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/7a0a143658e9/41598_2023_44557_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/8b225f1760ca/41598_2023_44557_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/4f03a0dbf07d/41598_2023_44557_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/b377bd37f55a/41598_2023_44557_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5343/10570311/d51303ec9efb/41598_2023_44557_Fig10_HTML.jpg

相似文献

1
The synthesis, thermal behaviour, spectral and structural characterization, and in silico prediction of pharmacokinetic parameters of tetraalkylammonium salts of non-steroidal anti-inflammatory drug nimesulide.非甾体抗炎药尼美舒利的四烷基铵盐的合成、热行为、光谱和结构表征以及药代动力学参数的计算机预测
Sci Rep. 2023 Oct 12;13(1):17268. doi: 10.1038/s41598-023-44557-x.
2
Dipolar Reorientations in Amorphous Nimesulide: A TSDC and DSC Study.非晶态尼美舒利中的偶极重取向:热刺激去极化电流和差示扫描量热法研究
Curr Drug Deliv. 2017;14(1):91-98. doi: 10.2174/1567201813666160510122023.
3
Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L-lysine-cyclodextrin complexes.环糊精和L-赖氨酸对尼美舒利水溶性的影响研究;尼美舒利-L-赖氨酸-环糊精复合物的分离与表征
J Pharm Sci. 1997 Apr;86(4):475-80. doi: 10.1021/js960298k.
4
Characterization and compaction behaviour of nimesulide crystal forms.尼美舒利晶型的表征及压缩行为
Int J Pharm. 2007 Sep 5;342(1-2):137-44. doi: 10.1016/j.ijpharm.2007.05.009. Epub 2007 May 13.
5
Structural insight and prediction of the pharmacokinetic parameters and toxicity of alkaline earth metal compounds strontium and barium with the non-steroidal anti-inflammatory drug nimesulide.碱性土金属化合物锶和钡与非甾体抗炎药尼美舒利的药代动力学参数和毒性的结构洞察和预测。
Dalton Trans. 2024 Apr 16;53(15):6501-6506. doi: 10.1039/d4dt00446a.
6
Sodium N-(methylsulfonyl)-N-(4-nitro-2-phenoxyphenyl)sulfamate: a water-soluble nimesulide prodrug for parenteral use.N-(甲基磺酰基)-N-(4-硝基-2-苯氧苯基)磺酰胺钠:一种可用于注射的水溶性尼美舒利前药。
Mol Pharm. 2010 Oct 4;7(5):1871-6. doi: 10.1021/mp1001137. Epub 2010 Jul 27.
7
Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling.B0AT1(SLC6A19)氨基酸转运体中的尼美舒利结合位点。通过蛋白脂质体转运测定和分子模拟揭示的抑制机制。
Biochem Pharmacol. 2014 Jun 1;89(3):422-30. doi: 10.1016/j.bcp.2014.03.014. Epub 2014 Apr 1.
8
Clinical pharmacokinetics of nimesulide.尼美舒利的临床药代动力学。
Clin Pharmacokinet. 1998 Oct;35(4):247-74. doi: 10.2165/00003088-199835040-00001.
9
Synthesis, crystal structure determination and Hirshfeld surface analysis of three new salt forms of creatinine with hydrobromic acid, 3-aminobenzoic acid and 3,5-dinitrobenzoic acid.合成、肌酐与氢溴酸、3-氨基苯甲酸和 3,5-二硝基苯甲酸三种新盐形式的晶体结构测定和 Hirshfeld 表面分析。
Acta Crystallogr C Struct Chem. 2022 Aug 1;78(Pt 8):437-448. doi: 10.1107/S2053229622006684. Epub 2022 Jul 11.
10
Involvement of electron and hydrogen transfers through redox metabolism on activity and toxicity of the nimesulide.通过氧化还原代谢的电子和氢转移对尼美舒利活性和毒性的影响。
J Mol Model. 2015 Jul;21(7):166. doi: 10.1007/s00894-015-2712-3. Epub 2015 Jun 6.

引用本文的文献

1
Crystal structure of the tetra-ethyl-ammonium salt of the non-steroidal anti-inflammatory drug nimesulide (polymorph II).非甾体抗炎药尼美舒利(多晶型物II)的四乙铵盐的晶体结构
Acta Crystallogr E Crystallogr Commun. 2024 Feb 20;80(Pt 3):314-317. doi: 10.1107/S2056989024001300. eCollection 2024 Mar 1.

本文引用的文献

1
Thermal Behavior of the Nimesulide-Salicylic Acid Eutectic Mixtures Prepared by Mechanosynthesis and Recrystallization.机械合成与重结晶法制备的尼美舒利-水杨酸低共熔混合物的热行为
Materials (Basel). 2021 Dec 14;14(24):7715. doi: 10.3390/ma14247715.
2
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.SwissADME:一个免费的网络工具,用于评估小分子的药代动力学、类药性和药物化学友善性。
Sci Rep. 2017 Mar 3;7:42717. doi: 10.1038/srep42717.
3
Nimesulide Silver Metallodrugs, Containing the Mitochondriotropic, Triaryl Derivatives of Pnictogen; Anticancer Activity against Human Breast Cancer Cells.
尼美舒利金属药物,含向线粒体性的、主族元素的三芳基衍生物;对人乳腺癌细胞的抗癌活性。
Inorg Chem. 2016 Sep 6;55(17):8681-96. doi: 10.1021/acs.inorgchem.6b01241. Epub 2016 Aug 11.
4
A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules.用煮鸡蛋预测小分子的胃肠道吸收和脑渗透
ChemMedChem. 2016 Jun 6;11(11):1117-21. doi: 10.1002/cmdc.201600182. Epub 2016 May 24.
5
The Cambridge Structural Database.剑桥结构数据库。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016 Apr;72(Pt 2):171-9. doi: 10.1107/S2052520616003954. Epub 2016 Apr 1.
6
Prediction of drug-ABC-transporter interaction--Recent advances and future challenges.药物与ABC转运蛋白相互作用的预测——最新进展与未来挑战
Adv Drug Deliv Rev. 2015 Jun 23;86:17-26. doi: 10.1016/j.addr.2015.03.001. Epub 2015 Mar 11.
7
Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.预测口服药物吸收的早期药物特征分析:现状与未满足的需求
Eur J Pharm Sci. 2014 Jun 16;57:173-99. doi: 10.1016/j.ejps.2013.10.015. Epub 2013 Nov 9.
8
Crystal engineering: from molecule to crystal.晶体工程:从分子到晶体。
J Am Chem Soc. 2013 Jul 10;135(27):9952-67. doi: 10.1021/ja403264c. Epub 2013 Jun 27.
9
Pharmaceutical cocrystals: an overview.药物共晶:概述。
Int J Pharm. 2011 Oct 31;419(1-2):1-11. doi: 10.1016/j.ijpharm.2011.07.037. Epub 2011 Aug 2.
10
Phase transformation in conformational polymorphs of nimesulide.尼美舒利构象多晶型中的相转变。
J Pharm Sci. 2011 Jun;100(6):2287-99. doi: 10.1002/jps.22464. Epub 2011 Jan 14.